全文获取类型
收费全文 | 27916篇 |
免费 | 2624篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 230篇 |
儿科学 | 1013篇 |
妇产科学 | 500篇 |
基础医学 | 3950篇 |
口腔科学 | 535篇 |
临床医学 | 3495篇 |
内科学 | 5246篇 |
皮肤病学 | 589篇 |
神经病学 | 2688篇 |
特种医学 | 719篇 |
外国民族医学 | 11篇 |
外科学 | 2796篇 |
综合类 | 401篇 |
一般理论 | 44篇 |
预防医学 | 3335篇 |
眼科学 | 838篇 |
药学 | 2160篇 |
中国医学 | 46篇 |
肿瘤学 | 1983篇 |
出版年
2022年 | 204篇 |
2021年 | 463篇 |
2020年 | 297篇 |
2019年 | 517篇 |
2018年 | 562篇 |
2017年 | 407篇 |
2016年 | 445篇 |
2015年 | 543篇 |
2014年 | 751篇 |
2013年 | 1095篇 |
2012年 | 1459篇 |
2011年 | 1666篇 |
2010年 | 923篇 |
2009年 | 791篇 |
2008年 | 1419篇 |
2007年 | 1414篇 |
2006年 | 1424篇 |
2005年 | 1392篇 |
2004年 | 1372篇 |
2003年 | 1188篇 |
2002年 | 1162篇 |
2001年 | 711篇 |
2000年 | 729篇 |
1999年 | 617篇 |
1998年 | 331篇 |
1997年 | 273篇 |
1996年 | 255篇 |
1995年 | 249篇 |
1994年 | 219篇 |
1993年 | 218篇 |
1992年 | 481篇 |
1991年 | 467篇 |
1990年 | 451篇 |
1989年 | 457篇 |
1988年 | 386篇 |
1987年 | 439篇 |
1986年 | 354篇 |
1985年 | 377篇 |
1984年 | 306篇 |
1983年 | 291篇 |
1982年 | 193篇 |
1981年 | 197篇 |
1980年 | 185篇 |
1979年 | 306篇 |
1978年 | 254篇 |
1977年 | 172篇 |
1975年 | 178篇 |
1974年 | 192篇 |
1973年 | 183篇 |
1972年 | 181篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Richard Kim Elaine Tan Emily Wang Amit Mahipal Dung-Tsa Chen Biwei Cao Fadzai Masawi Cindy Machado James Yu Dae Won Kim 《The oncologist》2020,25(12):e1893-e1899
Lessons Learned
- The combination of trametinib and sorafenib has an acceptable safety profile, albeit at doses lower than approved for monotherapy.
- Maximum tolerated dose is trametinib 1.5 mg daily and sorafenib 200 mg twice daily.
- The limited anticancer activity observed in this unselected patient population does not support further exploration of trametinib plus sorafenib in patients with hepatocellular carcinoma.
3.
Julia H. Vermylen Gordon J. Wood Elaine R. Cohen Jeffrey H. Barsuk William C. McGaghie Diane B. Wayne 《Journal of pain and symptom management》2019,57(3):682-687
Introduction
Physician communication impacts patient outcomes. However, communication skills, especially around difficult conversations, remain suboptimal, and there is no clear way to determine the validity of entrustment decisions. The aims of this study were to 1) describe the development of a simulation-based mastery learning (SBML) curriculum for breaking bad news (BBN) conversation skills and 2) set a defensible minimum passing standard (MPS) to ensure uniform skill acquisition among learners.Innovation
An SBML BBN curriculum was developed for fourth-year medical students. An assessment tool was created to evaluate the acquisition of skills involved in a BBN conversation. Pilot testing was completed to confirm improvement in skill acquisition and set the MPS.Outcomes
A BBN assessment tool containing a 15-item checklist and six scaled items was developed. Students' checklist performance improved significantly at post-test compared to baseline (mean 65.33%, SD = 12.09% vs mean 88.67%, SD = 9.45%, P < 0.001). Students were also significantly more likely to have at least a score of 4 (on a five-point scale) for the six scaled questions at post-test. The MPS was set at 80%, requiring a score of 12 items on the checklist and at least 4 of 5 for each scaled item. Using the MPS, 30% of students would require additional training after post-testing.Comments
We developed a SBML curriculum with a comprehensive assessment of BBN skills and a defensible competency standard. Future efforts will expand the mastery model to larger cohorts and assess the impact of rigorous education on patient care outcomes. 相似文献4.
5.
6.
7.
8.
9.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献10.
Ferdynand Hebal Elissa Port Catherine J. Hunter Bryan Malas Jared Green Marleta Reynolds 《Journal of pediatric surgery》2019,54(4):656-662